Teladoc Inc Aktie News

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.

Teladoc stock price crashed to a record low as demand for its services waned after the pandemic. It plunged to a low of $5.74, down sharply from the all-time high of $308, with its market capitalization falling from a high of $46 billion to the current $1 billion.

Teladoc's revenue and stock price soared in early pandemic days. But in recent years, the company has struggled with various challenges.

Medicare will no longer cover telemedicine services for many patients. This change will affect Teladoc Health, which was already struggling.

Sarepta Therapeutics' drug safety issues are overshadowing its innovative platform. Teladoc Health's financial results continue to worsen, and the stock looks unlikely to recover.

Teladoc Health, Inc. is downgraded to Sell due to persistent revenue declines and deteriorating segment economics. TDOC's Q3 2025 revenue fell 2% year-over-year, with U.S. revenue down 5% and BetterHelp segment shrinking further. Free cash flow guidance was narrowed, and monetization per member is weakening, increasing exposure to visit-driven volatility.

Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

New capabilities enable Teladoc Health's care teams to address a broader spectrum of health needs, delivering more value in virtual urgent care visits